Emerging studies suggest this peptide, a dual agonist targeting both GLP-1 and glucose-dependent insulinotropic polypeptide , may offer a promising development for weight management . Initial human trials https://graysongztg447567.blogdosaga.com/41467622/a-retatru-tide-compound-a-innovation-in-weight-control